As buzz around conversational AI reached a fever pitch last year, a new term began gaining traction: "AI agents."
Over the past twelve months, Google searches for AI agents have increased nearly tenfold. While the category of "agentic AI" may seem to have appeared from nowhere, it has quickly become one of the most talked-about trends in tech.
Yet, descriptions of agentic AI are still largely abstract, making it difficult to grasp what sets it apart or how it might apply in
Read More
Most Popular
AI Breakthrough Reveals 2025 AI Breakthrough Award Winners
What You Should Know:
- The 8th annual AI Breakthrough Awards have been announced, recognizing the leading companies, technologies, and products in the global Artificial Intelligence market. The awards, organized by the market intelligence firm AI Breakthrough, highlight the most innovative and impactful solutions across a wide spectrum of AI categories.
- This year, the program received over 5,000 nominations from more than 20 countries, reflecting the significant and
Read More
Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry
Healthcare is moving deeper into the value-based era. Metrics drive decisions, outcomes define quality, and performance data shapes reimbursement. Yet amid this transformation, inpatient psychiatry and behavioral healthcare remain the most notable outlier—excluded for a variety of reasons including stigmatization, subjectivity, and a high degree of variation in clinical operations from site to site.
Behavioral healthcare lacks the foundational standards and management models that have
Read More
Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound
What You Should Know:
- Omada Health, a virtual-first provider for chronic conditions, made a stellar public debut on the NASDAQ today, in a move that signals renewed investor confidence in the digital health market. The company's stock, trading under the ticker "OMDA," opened at $23 per share, a significant 21% jump from its initial public offering price of $19. The offering raised $150M.
- The successful launch marks a pivotal moment for the industry, following on the heels of
Read More
Lessons Learned from The Change Healthcare Cyberattack, One Year Later
Just over a year ago, Change Healthcare was the target of the largest medical data breach in U.S. history. The cyberattack impacted over 190 million people in the U.S. and halted the healthcare technology company’s systems, causing months of outages.
Change Healthcare provides solutions and services to hundreds of thousands of healthcare providers nationwide and processes billions of transactions each year. This attack had a massive ripple effect, preventing transactions, payments, and
Read More
Medtronic to Separate Diabetes Business into New Standalone Company
What You Should Know:
- Medtronic today announced its strategic decision to separate its Diabetes business into a new, independent, publicly traded company ("New Diabetes Company").
- The move aims to create a more focused Medtronic, with a simplified portfolio concentrated on high-margin growth markets, while simultaneously establishing a scaled, independent leader in the diabetes sector.
- The separation is expected to be completed within 18 months through a series of
Read More
HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing
What You Should Know:
- The U.S. Department of Health and Human Services (HHS) announced it is taking immediate action to implement President Donald J. Trump’s Executive Order, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.”
- Under the leadership of President Trump, HHS Secretary Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services (CMS) Administrator Dr. Mehmet Oz, the Department has outlined specific targets for
Read More
Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services
What You Should Know:
- Regeneron Pharmaceuticals, Inc. announced it has been named the successful bidder in the bankruptcy auction for substantially all of the assets of 23andMe Holding Co.
- Regeneron plans to acquire 23andMe’s Personal Genome Service® (PGS), Total Health and Research Services business lines, along with its extensive Biobank and associated assets, for $256 million.
- Under the terms of the proposed acquisition, Regeneron intends for 23andMe to continue all
Read More
CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft
What You Should Know:
- CureIS Healthcare, Inc., a company specializing in information technology solutions for the healthcare industry, has filed a lawsuit against EHR giant Epic Systems Corporation.
- The complaint, lodged in the U.S. District Court for the Northern District of California on May 13, 2025, accuses Epic of engaging in a multifaceted scheme to unlawfully stifle competition, interfere with CureIS's business and customer relationships, misappropriate trade secrets, and
Read More
The Evolving Physician Advisor: From UM to Value-Based Care & AI
In today’s complex healthcare landscape, Physician Advisors (PAs) play an increasingly vital role in ensuring hospitals and health systems function smoothly, efficiently, and with a focus on patient-centered care. As healthcare spending continues to rise, the need for professionals who can effectively navigate the intersection of clinical practice and financial stewardship has never been greater.
What is
Read More
